Related Experiment Video
Updated: Nov 15, 2025

Modeling the Effects of Hemodynamic Stress on Circulating Tumor Cells using a Syringe and Needle
Published on: April 27, 2021
Tumor-related stress regulates functional plasticity of MDSCs
Jessica K Mandula1, Paulo C Rodriguez1
1Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Abstract:
Myeloid-derived suppressor cells (MDSCs) impair protective anti-tumor immunity and remain major obstacles that stymie the effectiveness of promising cancer therapies. Diverse tumor-derived stressors galvanize the differentiation, intra-tumoral expansion, and immunomodulatory function of MDSCs. These tumor-associated 'axes of stress' underwrite the immunosuppressive programming of MDSCs in cancer and contribute to the phenotypic/functional heterogeneity that characterize tumor-MDSCs. This review discusses various tumor-associated axes of stress that direct MDSC development, accumulation, and immunosuppressive function, as well as current strategies aimed at overcoming the detrimental impact of MDSCs in cancer. To better understand the constellation of signals directing MDSC biology, we herein summarize the pivotal roles, signaling mediators, and effects of reactive oxygen/nitrogen species-related stress, chronic inflammatory stress, hypoxia-linked stress, endoplasmic reticulum stress, metabolic stress, and therapy-associated stress on MDSCs. Although therapeutic targeting of these processes remains mostly pre-clinical, intercepting signaling through the axes of stress could overcome MDSC-related immune suppression in tumor-bearing hosts.
Insights
Myeloid-derived suppressor cells (MDSCs) hinder anti-tumor immunity and cancer therapies. Targeting tumor-associated stress axes that drive MDSC immunosuppression offers a promising strategy to overcome these obstacles in cancer treatment.
Area of Science:
- Immunology
- Oncology
Background:
- Myeloid-derived suppressor cells (MDSCs) are critical regulators of the tumor immune microenvironment.
- MDSCs suppress anti-tumor immunity, representing a significant barrier to effective cancer therapies.
Purpose of the Study:
- To review tumor-associated stress axes that influence MDSC development, accumulation, and immunosuppressive functions.
- To discuss current therapeutic strategies targeting these stress pathways to overcome MDSC-mediated immune suppression.
Main Methods:
- Literature review of studies investigating MDSC biology and tumor-associated stress.
- Synthesis of information on various stress pathways including oxidative, inflammatory, hypoxic, ER, metabolic, and therapy-induced stress.
Main Results:
- Diverse tumor-derived stressors, termed 'axes of stress,' orchestrate MDSC differentiation, expansion, and immunosuppressive programming.
- Specific stress axes discussed include reactive oxygen/nitrogen species, chronic inflammation, hypoxia, endoplasmic reticulum stress, metabolic stress, and therapy-associated stress.
Conclusions:
- Understanding these stress axes is crucial for deciphering MDSC heterogeneity and function in cancer.
- Targeting these tumor-associated stress pathways holds potential for pre-clinical therapeutic strategies to enhance anti-tumor immunity.
More Related Videos
09:28Isolation of Primary Human Colon Tumor Cells from Surgical Tissues and Culturing Them Directly on Soft Elastic Substrates for Traction Cytometry
Published on: June 4, 2015
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014
Related Concept Videos
Abnormal Proliferation
Psychoneuroimmunology: Diabetes and Cancer
Mesenchymal Stem Cells
The Tumor Microenvironment